Large‐cell neuroendocrine carcinoma of the kidney effectively treated by nivolumab and ipilimumab
This case demonstrates the efficacy of treatment with the immune-checkpoint inhibitors against large-cell neuroendocrine carcinoma of the kidney.
Authors
- Takashi Kabuto
- Hisato Kobayashi (ORCID: https://orcid.org/0000-0002-1346-6729)
- So Inamura (ORCID: https://orcid.org/0000-0002-1261-5059)
- Yoshiaki Imamura (ORCID: https://orcid.org/0000-0001-6439-0237)
- Naoki Terada (ORCID: https://orcid.org/0009-0005-1082-6089)
- N. Okubo (ORCID: https://orcid.org/0009-0009-3329-4512)
- Masato Fukushima (ORCID: https://orcid.org/0000-0001-9120-9819)
- Minekatsu Taga (ORCID: https://orcid.org/0000-0002-1767-9799)
- Masaya Seki
- Junya Kimura
Institutions
- University of Fukui (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1002/iju5.12798
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00